Continuous Renal Replacement Therapy Market by Product, & Dialysate, Modality, Adoption & Procedures, and Region - Forecast to 2022

Continuous Renal Replacement Therapy Market by Product, & Dialysate, Modality, Adoption & Procedures, and Region - Forecast to 2022

  • July 2017 •
  • 191 pages •
  • Report ID: 5025062 •
  • Format: PDF
The global CRRT market is projected to reach USD 1.53 billion by 2022 from USD 1.09 billion in 2017, at a CAGR of 7.0%. Increasing global incidence of acute kidney injury, growing number of ICU patients, increasing incidence of sepsis, and tehcnologcal advancements are some of the factors driving the growth of the CRRT market. However, high procedural cost of CRRT and stringent regulatory guidelines for CRRT in North America are expected to hinder market growth.

“Hemofilters to form the largest segment of CRRT disposables as of 2017”
On the basis of product, CRRT disposables segment is further sub-segmented to the bloodline sets, hemofilters, and other disposables (such as vascular access catheters and CRRT accessories, including drainage bags, ancillaries, stop cocks, syringes, and priming solutions). The hemofilters segment is estimated to account for the largest share of the disposables market due to the development of novel hemofilters and their increasing use in CRRT procedures.

“Continuous Venovenous Hemofiltration (CVVH) modality segment expected to be the largest segment during 2017-2022”
Based on modality, the CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The The CVVH modality is estimated to account for the largest share of the global CRRT market owing to the wide adoption of this modality among healthcare providers.

“Asia-Pacific is expected to register the highest growth rate in the CRRT market”
Geographically, the CRRT market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the large acute kidney injury patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across Asian countries.

Breakdown of supply-side primary interviews:

• By Company Type - Tier 1 – 40%, Tier 2 – 25%, and Tier 3 – 35%
• By Designation – C level – 26%, Director level – 30%, and Others – 44%
• By Region – North America - 34%, Europe – 26%, APAC – 23%, and RoW – 17%

The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), and Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

Research Coverage

This report studies the CRRT market based on product and modality. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and prospects in the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the CRRT market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the recommended strategies for strengthening their market shares.

We are very sorry, but an error occurred.
Please contact if the problem remains.